25th Feb 2016 09:31
LONDON (Alliance News) - Oxford Pharmascience Group PLC on Thursday said it has appointed former Reckitt Benckiser Group PLC director Anand Sharma as a non-executive director.
Sharma has worked in the pharmaceutical and consumer healthcare industry for more than 40 years and was most recently the global category director for new business development at Reckitt Benckiser Healthcare, which owns products such as Nurofen.
"I am delighted to welcome Anand to the board as he brings solid and impressive experience from within one of the best known over-the-counter consumer healthcare companies. His knowledge of the sector and awareness of the issues facing OTC healthcare brands will be of great help to the company as it looks to commercialise the OXPzeroTM assets," Chairman David Norwood said in a statement.
Shares in Oxford Pharmascience were trading up 0.6% at 4.90 pence on Thursday morning.
By Karolina Kaminska; [email protected] @KarolinaAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Pharmascience Group